702
Views
33
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for migraine treatment

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Paolo Martelletti & Maria Adele Giamberardino. (2019) Advances in orally administered pharmacotherapy for the treatment of migraine. Expert Opinion on Pharmacotherapy 20:2, pages 209-218.
Read now
Maria Adele Giamberardino, Giannapia Affaitati, Raffaele Costantini, Francesco Cipollone & Paolo Martelletti. (2017) Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab. Journal of Pain Research 10, pages 2751-2760.
Read now
Stephen Silberstein. (2017) AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine. Expert Review of Clinical Pharmacology 10:8, pages 821-832.
Read now
Paolo Martelletti. (2017) Acute treatment of migraine: quo vadis?. Expert Opinion on Pharmacotherapy 18:11, pages 1035-1037.
Read now
Claudio Tana, Maria Adele Giamberardino & Francesco Cipollone. (2017) microRNA profiling in atherosclerosis, diabetes, and migraine. Annals of Medicine 49:2, pages 93-105.
Read now
Matilde Capi, Fernando de Andrés, Luana Lionetto, Giovanna Gentile, Fabiola Cipolla, Andrea Negro, Marina Borro, Paolo Martelletti & Martina Curto. (2017) Lasmiditan for the treatment of migraine. Expert Opinion on Investigational Drugs 26:2, pages 227-234.
Read now
Peiwei Hong & Yao Liu. (2017) Calcitonin gene-related peptide antagonism for acute treatment of migraine: a meta-analysis. International Journal of Neuroscience 127:1, pages 20-27.
Read now
Paolo Martelletti, Maria Adele Giamberardino & Dimos-Dimitrios Mitsikostas. (2016) Greater occipital nerve as target for refractory chronic headaches: from corticosteroid block to invasive neurostimulation and back. Expert Review of Neurotherapeutics 16:8, pages 865-866.
Read now
Stephen D Silberstein. (2016) Considerations for management of migraine symptoms in the primary care setting. Postgraduate Medicine 128:5, pages 523-537.
Read now
Emmanuele Tafuri, Donato Santovito, Velia de Nardis, Pamela Marcantonio, Camilla Paganelli, Giannapia Affaitati, Marco Bucci, Andrea Mezzetti, Maria Adele Giamberardino & Francesco Cipollone. (2015) MicroRNA profiling in migraine without aura: Pilot study. Annals of Medicine 47:6, pages 468-473.
Read now

Articles from other publishers (23)

Mahsa Bagherzadeh-Fard, Mohammad Amin Yazdanifar, Mona Sadeghalvad & Nima Rezaei. (2023) Erenumab efficacy in migraine headache prophylaxis: A systematic review. International Immunopharmacology 117, pages 109366.
Crossref
M. Koch, Z. Katsarava, C. Baufeld, K. Schuh, A. Gendolla, A. Straube, W. von Pannwitz, W. E. Hofmann & S. Ortler. (2021) Migraine patients in Germany - need for medical recognition and new preventive treatments: results from the PANORAMA survey. The Journal of Headache and Pain 22:1.
Crossref
Maria Clara Tonini, Alessandra Fiorencis, Rosario Iannacchero, Mauro Zampolini, Antonietta Cappuccio, Raffaella Raddino, Elisabetta Grillo, Maria Albanese, Gianni Allais, Marco André Bassano, Filippo Brighina, Terenzio Carboni, Fabio Frediani, Licia Grazzi, Carmela Mastrandrea, Franca Moschiano, Maria Gabriella Poeta, Angelo Ranieri, Renato Turrini & Maria Giulia Marini. (2021) Narrative Medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project. Neurological Sciences 42:12, pages 5277-5288.
Crossref
Komal Latif, Arif-ullah Khan, Muhammad Izhar Ul Haque & Komal Naeem. (2021) Bergapten Attenuates Nitroglycerin-Induced Migraine Headaches through Inhibition of Oxidative Stress and Inflammatory Mediators. ACS Chemical Neuroscience 12:18, pages 3303-3313.
Crossref
Paul A DeJulio, Joshua K Perese, Nathaniel M Schuster & Jessica C Oswald. (2021) Lasmiditan for the acute treatment of migraine. Pain Management 11:5, pages 437-449.
Crossref
Giannapia Affaitati, Raffaele Costantini, Claudio Tana, Francesco Cipollone & Maria Adele Giamberardino. (2019) Co-occurrence of pain syndromes. Journal of Neural Transmission 127:4, pages 625-646.
Crossref
Maria Adele Giamberardino, Giannapia Affaitati, Raffaele Costantini, Martina Guglielmetti & Paolo Martelletti. (2020) Acute headache management in emergency department. A narrative review. Internal and Emergency Medicine 15:1, pages 109-117.
Crossref
Marina Borro, Martina Guglielmetti, Maurizio Simmaco, Paolo Martelletti & Giovanna Gentile. (2019) The future of pharmacogenetics in the treatment of migraine. Pharmacogenomics 20:16, pages 1159-1173.
Crossref
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, Maria Diana Naturale, Luigi Antonio Morrone, Giacinto Bagetta, Paolo Tonin & Maria Tiziana Corasaniti. (2019) New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies. Frontiers in Pharmacology 10.
Crossref
Reimar Wernich Thomsen, Szimonetta Komjáthiné Szépligeti, Fei Xue, Lars Pedersen, Henrik Toft Sørensen & Vera Ehrenstein. (2019) Patterns of initial migraine treatment in Denmark: A population-based study. Pharmacoepidemiology and Drug Safety 28:3, pages 322-329.
Crossref
Theodoros Mavridis, Chrysa Koniari, Nikolaos Fakas & Dimos D. Mitsikostas. (2019) Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies: Adverse Effects. What Do We Really Know? A Literature Review. EMJ Innovations, pages 64-72.
Crossref
Sameer Jain, Hsiangkuo Yuan, Nicole Spare & Stephen D Silberstein. (2018) Erenumab in the treatment of migraine. Pain Management 8:6, pages 415-426.
Crossref
Edoardo Caronna, Victor José Gallardo, Natalia Hernández-Beltrán, Marta Torres-Ferrus & Patricia Pozo-Rosich. (2018) OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse. Frontiers in Neurology 9.
Crossref
Yongguo Tang, Junfang Kang, Yu Zhang & Xuejun Zhang. (2017) Influence of greater occipital nerve block on pain severity in migraine patients: A systematic review and meta-analysis. The American Journal of Emergency Medicine 35:11, pages 1750-1754.
Crossref
Lanfranco Pellesi, Simona Guerzoni & Luigi Alberto Pini. (2017) Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date. Clinical Pharmacology in Drug Development 6:6, pages 534-547.
Crossref
Louis Jacob & Karel Kostev. (2017) Prescription Patterns and the Cost of Migraine Treatments in German General and Neurological Practices. Pain Practice 17:6, pages 747-752.
Crossref
Giannapia Affaitati, Paolo Martelletti, Mariangela Lopopolo, Claudio Tana, Francesca Massimini, Francesco Cipollone, Domenico Lapenna, Maria Adele Giamberardino & Raffaele Costantini. (2017) Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache. Pain Practice 17:3, pages 392-401.
Crossref
Qasim Aziz & Maria Adele Giamberardino. 2017. Comorbidities in Headache Disorders. Comorbidities in Headache Disorders 65 84 .
Fabio Antonaci, Natascia Ghiotto, Shizheng Wu, Ennio Pucci & Alfredo Costa. (2016) Recent advances in migraine therapy. SpringerPlus 5:1.
Crossref
Maria Adele Giamberardino, Giannapia Affaitati, Paolo Martelletti, Claudio Tana, Andrea Negro, Domenico Lapenna, Martina Curto, Cosima Schiavone, Luisa Stellin, Francesco Cipollone & Raffaele Costantini. (2016) Impact of migraine on fibromyalgia symptoms. The Journal of Headache and Pain 17:1.
Crossref
Maria Adele Giamberardino, Giannapia Affaitati, Martina Curto, Andrea Negro, Raffaele Costantini & Paolo Martelletti. (2016) Anti-CGRP monoclonal antibodies in migraine: current perspectives. Internal and Emergency Medicine 11:8, pages 1045-1057.
Crossref
Olga Kuzawińska, Krzysztof Lis, Grzegorz Cessak, Dagmara Mirowska-Guzel & Ewa Bałkowiec-Iskra. (2016) Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment. Neurologia i Neurochirurgia Polska 50:6, pages 463-467.
Crossref
Maria Adele Giamberardino, Dimos-Dimitrios Mitsikostas & Paolo Martelletti. (2015) Update on Medication-Overuse Headache and Its Treatment. Current Treatment Options in Neurology 17:8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.